![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
805kB |
| Item Type: | Review |
|---|---|
| Title: | Bradykinin receptors in metabolic disorders: a comprehensive review |
| Creators Name: | Branquinho, Jéssica, Neves, Raquel Leão, Bader, Michael and Pesquero, João Bosco |
| Abstract: | The kallikrein–kinin system and its B1 and B2 receptors are key regulators in metabolic disorders such as obesity, diabetes, and insulin resistance. Obesity, a chronic and multifactorial condition often associated with comorbidities like type 2 diabetes and dyslipidemia, remains poorly understood at the metabolic level. The kinin B2 receptor (B2R) is involved in blood pressure regulation and glucose metabolism, promoting glucose uptake in skeletal muscle via bradykinin. Studies in B2R-KO mice demonstrate that the absence of this receptor predisposes animals to glucose intolerance under a high-fat diet and impairs adaptive thermogenesis, indicating a protective role for B2R in metabolic homeostasis and insulin sensitivity. In contrast, the kinin B1 receptor (B1R) is inducible under pathological conditions and is activated by kinin metabolites. Mouse models lacking B1R exhibit improved metabolic profiles, including protection against high-fat diet-induced obesity and insulin resistance, enhanced energy expenditure, and increased leptin sensitivity. B1R inactivation in adipocytes enhances insulin responsiveness and glucose tolerance, supporting its role in the development of insulin resistance. Moreover, B1R deficiency improves energy metabolism and thermogenic responses to adrenergic and cold stimuli, promoting the activation of brown adipose tissue and the browning of white adipose tissue. Collectively, these findings suggest that B1R and B2R represent promising therapeutic targets for the treatment of metabolic disorders. |
| Keywords: | Bradykinin Receptors, Kallikrein-Kinin System, Kinin B1 Receptor, Kinin B2 Receptor, Metabolism, Metabolic Disorders, Obesity, Diabetes, Insulin Resistance, Adipose Tissue, Animals, Mice |
| Source: | Drugs and Drug Candidates |
| ISSN: | 2813-2998 |
| Publisher: | MDPI |
| Volume: | 4 |
| Number: | 3 |
| Page Range: | 37 |
| Date: | September 2025 |
| Official Publication: | https://doi.org/10.3390/ddc4030037 |
Repository Staff Only: item control page
